» Articles » PMID: 16565084

Concordant Regulation of Gene Expression by Hypoxia and 2-oxoglutarate-dependent Dioxygenase Inhibition: the Role of HIF-1alpha, HIF-2alpha, and Other Pathways

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Mar 28
PMID 16565084
Citations 246
Authors
Affiliations
Soon will be listed here.
Abstract

Studies of gene regulation by oxygen have revealed novel signal pathways that regulate the hypoxia-inducible factor (HIF) transcriptional system through post-translational hydroxylation of specific prolyl and asparaginyl residues in HIF-alpha subunits. These oxygen-sensitive modifications are catalyzed by members of the 2-oxoglutarate (2-OG) dioxygenase family (PHD1, PHD2, PHD3, and FIH-1), raising an important question regarding the extent of involvement of these and other enzymes of the same family in directing the global changes in gene expression that are induced by hypoxia. To address this, we compared patterns of gene expression induced by hypoxia and by a nonspecific 2-OG-dependent dioxygenase inhibitor, dimethyloxalylglycine (DMOG), among a set of 22,000 transcripts, by microarray analysis of MCF7 cells. By using short interfering RNA-based suppression of HIF-alpha subunits, we also compared responses that were dependent on, or independent of, the HIF system. Results revealed striking concordance between patterns of gene expression induced by hypoxia and by DMOG, indicating the central involvement of 2-OG-dependent dioxygenases in oxygen-regulated gene expression. Many of these responses were suppressed by short interfering RNAs directed against HIF-1alpha and HIF-2alpha, with HIF-1alpha suppression manifesting substantially greater effects than HIF-2alpha suppression, supporting the importance of HIF pathways. Nevertheless, the definition of genes regulated by both hypoxia and DMOG, but not HIF, distinguished other pathways most likely involving the action of 2-OG-dependent dioxygenases on non-HIF substrates.

Citing Articles

Rescuing DNMT1 fails to fully reverse the molecular and functional repercussions of its loss in mouse embryonic stem cells.

Elder E, Lemieux A, Legault L, Caron M, Bertrand-Lehouillier V, Dupas T Nucleic Acids Res. 2025; 53(4).

PMID: 39997223 PMC: 11851107. DOI: 10.1093/nar/gkaf130.


Significance of Malic Enzyme 1 in Cancer: A Review.

Fujiwara-Tani R, Nakashima C, Ohmori H, Fujii K, Luo Y, Sasaki T Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996805 PMC: 11854147. DOI: 10.3390/cimb47020083.


Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures.

Di Giovannantonio M, Hartley F, Elshenawy B, Barberis A, Hudson D, Shafique H Cell Genom. 2025; 5(2):100764.

PMID: 39892389 PMC: 11872601. DOI: 10.1016/j.xgen.2025.100764.


Nanoscale Systems for Local Activation of Hypoxia-Inducible Factor-1 Alpha: A New Approach in Diabetic Wound Management.

Saber S, Abdelhady R, Elhemely M, Elmorsy E, Hamad R, Abdel-Reheim M Int J Nanomedicine. 2024; 19:13735-13762.

PMID: 39723173 PMC: 11669355. DOI: 10.2147/IJN.S497041.


Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α.

Wang S, Awad K, Chen L, Siddique M, Ferreyra G, Wang C Am J Physiol Lung Cell Mol Physiol. 2024; 327(4):L503-L519.

PMID: 39159362 PMC: 11482463. DOI: 10.1152/ajplung.00077.2024.